Manulife (Manufacturers Life Insurance)’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-272
Closed -$9K 4365
2018
Q1
$9K Sell
272
-990
-78% -$34.7K ﹤0.01% 3956
2017
Q4
$41K Buy
1,262
+211
+20% +$6.6K ﹤0.01% 3592
2017
Q3
$33K Sell
1,051
-827
-44% -$24.3K ﹤0.01% 3569
2017
Q2
$52K Sell
1,878
-820
-30% -$21.3K ﹤0.01% 3481
2017
Q1
$70K Sell
2,698
-374
-12% -$9.3K ﹤0.01% 3281
2016
Q4
$70K Sell
3,072
-1,173
-28% -$28.1K ﹤0.01% 3345
2016
Q3
$111K Sell
4,245
-1,032
-20% -$25.8K ﹤0.01% 3169
2016
Q2
$119K Buy
5,277
+1,291
+32% +$30.7K ﹤0.01% 3141
2016
Q1
$85K Buy
3,986
+1,712
+75% +$39.1K ﹤0.01% 3119
2015
Q4
$72 Sell
2,274
-3,912
-63% -$120K ﹤0.01% 3194
2015
Q3
$172 Buy
6,186
+3,991
+182% +$139K ﹤0.01% 2772
2015
Q2
$78 Buy
+2,195
New +$71.7K ﹤0.01% 3310

Other funds holding SBIO

Manulife (Manufacturers Life Insurance)'s SBIO Position: Q2 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2018, closing a stake of 272 shares — an estimated $9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SBIO in Q2 2015 and held it in 12 quarters. The position peaked at $119K in Q2 2016. 45 funds tracked by Wall St. Rank hold SBIO as of Q2 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 272 ALPS Medical Breakthroughs ETF shares in Q2 2018, an estimated $9K.
  • Manulife (Manufacturers Life Insurance) first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and held it in 12 quarters.
  • Manulife (Manufacturers Life Insurance)'s ALPS Medical Breakthroughs ETF position peaked at $119K in Q2 2016.
  • 45 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2018, filed 14 Aug 2018.